Researchers at the University of Virginia Brain Institute and UVA School of Medicine will conduct a trial to see if the ...

Analysts were unfazed by the news that Takeda will cease development of soticlestat after Phase III failures, while ...

Takeda has axed plans to seek approval for its failed epilepsy drug candidate soticlestat. The Japanese drugmaker pulled the ...

Using a single-cell sequencing technique, Brazilian researchers have created the first cell atlas of focal cortical dysplasia ...

A new international study has unveiled critical insights in understanding post-traumatic epilepsy (PTE), a condition that can ...

EpiScalp could significantly reduce false positives and spare patients from medication side effects, driving restrictions, ...

Jan. 22, 2025 — Doctors could soon reduce epilepsy misdiagnoses by up to 70% using a new tool that turns routine electroencephalogram, or EEG, tests that appear normal into highly accurate ...

Collaborative research is driving the development of future treatments to ease symptoms of autism and epilepsy. The ...

NeuroPace, Inc. (NASDAQ:NPCE), a medical device company specializing in neurological disorders with a market capitalization of $439 million, has been making significant strides in the epilepsy ...

Maternal psychologic distress between the first and second halves of pregnancy is associated with epilepsy in children aged 1 to 3.

Creative agency Boldspace has won 2025’s Creative Shootout, earning Epilepsy Action as a new client, a £10,000 prize and a £350,000 media fund to help promote their campaign.